
供应Cabozantinib(XL184)849217-68-1
发布时间:01月28日
详细说明
XL184(Cabozantinib) 口服酪氨酸激酶抑制剂主要以与前列腺癌增长与扩散有关的MET和VEGFR2酪氨酸激酶为靶点,抑制肿瘤的转移和血管生成
Cabozantinib(XL184)(for lab research use only )
Cas no.: 849217-68-1
Package: 1g/package, 10g/package
Purity(HPLC ): 99%
Delivery: in stock.
we offer the best quality with most attractive price
whsrtech@yahoo.com.cn
wang_lily882008@hotmail.com
http://www.whsrtech.com